Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition | Health Care Economics, Insurance, Payment | JAMA

This cross-sectional study identified the prevalence of patents on risk evaluation and mitigation strategies and their association with delaying generic competi

Related Keywords

Virginia ,United States ,Boston ,Massachusetts ,Jodyw Zylke ,Karen Lasser ,Kristin Walter ,Program On Regulation ,Drug Administration ,Commonwealth Fund ,Virginia University Hodge Research Grant ,Microsoft ,Orange Book ,Deputy Editors ,Ameet Sarpatwari ,Interest Disclosures ,West Virginia University Hodge ,